OncoMatch/Clinical Trials/NCT07053033
Laser Interstitial Thermal Therapy (LITT) or Surgery and Adjuvant Reirradiation for Recurrent Brain Metastases (LaSAR BeaM)
Is NCT07053033 recruiting? Yes, currently enrolling (Jun 2026). This Phase 2 trial studies non-drug interventions for brain metastases.
standard paradigm for management of patients who present with concern for recurrence of brain metastases following initial stereotactic radiosurgery (SRS).
Check if I qualifyExtracted eligibility criteria
Disease stage
Metastatic disease required
Prior therapy
Must have received: stereotactic radiosurgery — brain metastasis
solid tumor brain metastasis that has received prior stereotactic radiosurgery ≥ 3 months prior to study enrollment
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- The University of Texas M. D. Anderson Cancer Center · Houston, Texas
Showing up to 5 US sites.
See all sites on ClinicalTrials.gov →Frequently asked questions
Is NCT07053033 currently recruiting?
Yes, this trial is currently recruiting patients.
Is prior treatment required for enrollment?
Yes. Patients must have previously received stereotactic radiosurgery.
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify